Clinical Trial Update: A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment

View source ↗

Summary

A completed clinical trial in Taiwan examined COPD flare-ups in patients who started LABA/LAMA or LAMA therapy based on medical records.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• LABA/LAMA
• LAMA (long-acting muscarinic antagonist)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2022-03-11